Amaros AI is a AI & Biomarker-driven Clinical Trials.
Amaros AI has raised $1.3M in total funding. The most recent round was Series A. The last funding was announced in April 2025.
Amaros AI's investors include SmartGateVC.
Amaros AI is headquartered in Menlo Park, United States.
Amaros AI is a AI & Biomarker-driven Clinical Trials.
Amaros AI is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amaros AI — Funding & Investors." VCBacked, April 1, 2025, https://www.vcbacked.co/company/amaros-ai. Accessed September 30, 2026.
VCBacked. (2025). Amaros AI — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/amaros-ai
{{cite web |title=Amaros AI — Funding & Investors |url=https://www.vcbacked.co/company/amaros-ai |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated